|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/68 | |
| C07D 401/14 | |||
| C07K 14/525 | |||
| C07D 471/00 | |||
| C07K 14/705 |
| (11) | Patento numeris | 3311167 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15784066.1 |
| Europos patento paraiškos padavimo data | 2015-10-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/074490 |
| Data | 2015-10-22 |
| (87) | Numeris | WO 2016/202411 |
| Data | 2016-12-22 |
| (30) | Numeris | Data | Šalis |
| 201510758 | 2015-06-18 | GB |
| (72) |
O`CONNELL, James Philip, GB
PORTER, John Robert, GB
LAWSON, Alastair, GB
KROEPLIEN, Boris,, GB
RAPECKI, Stephen Edward, GB
NORMAN, Timothy John, GB
MCMILLAN, David James, GB
WARRELLOW, Graham John, GB
BROOKINGS, Daniel Christopher, GB
ALEXANDER, Rikki Peter, GB
|
| (73) |
UCB Biopharma SRL,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (54) | MODULATION OF MEMBERS OF THE TNF-SUPERFAMILY |
| MODULATION OF MEMBERS OF THE TNF-SUPERFAMILY |